首页|瑞芬太尼联合依托咪酯和丙泊酚对骨科全麻患者的临床应用对比

瑞芬太尼联合依托咪酯和丙泊酚对骨科全麻患者的临床应用对比

扫码查看
目的 对比"瑞芬太尼联合依托咪酯和丙泊酚"和"瑞芬太尼联合丙泊酚"对骨科全麻手术患者的临床效果.方法 选择 2022 年 1 月至 2024 年 6 月在洛阳市中心医院接受全麻手术治疗的 74 例骨科患者,并根据麻醉方案分为研究组(38 例)和对照组(36 例).研究组患者采用"依托咪酯注射液+丙泊酚注射液+注射用盐酸瑞芬太尼"麻醉和依托咪酯注射液维持麻醉方案,对照组患者采用"丙泊酚注射液+注射用盐酸瑞芬太尼"麻醉和丙泊酚注射液维持麻醉方案.对比两组麻醉诱导时间、苏醒时间、定向力恢复时间以及麻醉诱导过程患者不同时间点的血流动力学变化,统计对比两组患者麻醉诱导过程的不良反应,并评估麻醉优良率.结果 研究组患者麻醉诱导时间、苏醒时间及定向力恢复时间均短于对照组患者,差异有统计学意义(P<0.05).麻醉诱导过程中,两组患者麻醉基线(T0)各血流动力学指标结果对比差异无统计学意义(P>0.05);意识消失时(T1)研究组患者的舒张压和心率(HR)结果高于对照组,差异有统计学意义(P<0.05);插管时(T2)以及插管后 5 min(T4),研究组患者收缩压、舒张压、平均动脉压(MAP)、心率(HR)均显著高于对照组,差异有统计学意义(P<0.05);而插管后 1 min(T3),研究组患者的舒张压、MAP及HR监测结果显著高于对照组,差异有统计学意义(P<0.05).研究组患者麻醉期间不良反应发生率(2.63%)低于对照组(22.22%),差异有统计学意义(P<0.05);研究组麻醉优良率(97.37%)高于对照组(75.00%),差异有统计学意义(P<0.05).结论 瑞芬太尼联合依托咪酯及丙泊酚作为骨科全麻手术患者的麻醉用药,相较于瑞芬太尼联合丙泊酚更有助于提升麻醉质量和苏醒质量,稳定患者麻醉期间的血流动力学,降低麻醉期间麻醉相关不良反应发生率.
Comparison of the Clinical Application of Remifentanil Combined with Etomidate and Propofol in Orthopedic General Anesthesia Patients
Objective To compare the clinical effects of"remifentanil combined with etomidate and propofol"and"remifentanil combined with propofol"in patients undergoing orthopedic general anesthesia.Methods A total of 74 orthopedic patients who underwent general anesthesia at Luoyang Central Hospital from January 2022 to June 2024 were selected and divided into a study group(n=38)and a control group(n=36)based on the anesthesia regimen.The study group received anesthesia with"etomidate injection+propofol injection+remifentanil hydrochloride injection"and maintained anesthesia with etomidate.The control group received anesthesia with"propofol injection+remifentanil hydrochloride injection"and maintained anesthesia with propofol.The two groups were compared in terms of anesthesia induction time,recovery time,orientation recovery time,hemodynamic changes at different time points during anesthesia induction,the incidence of adverse reactions,and the quality of anesthesia.Results The anesthesia induction time,recovery time,and orientation recovery time in the study group were significantly shorter than those in the control group(P<0.05).During anesthesia induction,there were no significant differences in baseline hemodynamic indicators between the two groups at time point T0(P>0.05).At the point of loss of consciousness(T1),the diastolic pressure and heart rate(HR)in the study group were significantly higher than those in the control group(P<0.05).At intubation(T2)and 5 minutes post-intubation(T4),the systolic pressure,diastolic pressure,mean arterial pressure(MAP),and HR were all significantly higher in the study group than in the control group(P<0.05).One minute after intubation(T3),the study group's diastolic pressure,MAP,and HR were also significantly higher than those in the control group(P<0.05).The incidence of adverse reactions during anesthesia was significantly lower in the study group(2.63%)compared to the control group(22.22%)(P<0.05).Additionally,the quality of anesthesia was significantly better in the study group(97.37%)compared to the control group(75.00%)(P<0.05).Conclusion The combination of remifentanil with etomidate and propofol for anesthesia in orthopedic patients is more beneficial than remifentanil combined with propofol alone in enhancing anesthesia quality and recovery quality,stabilizing hemodynamics during anesthesia,and reducing the incidence of anesthesia-related adverse reactions.

general anesthesiaremifentaniletomidatepropofolhemodynamics

王辉

展开 >

洛阳市中心医院 麻醉科,河南 洛阳 471000

全麻手术 瑞芬太尼 依托咪酯 丙泊酚 血流动力学

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(12)